VRCA
VRCA
NASDAQ · Pharmaceuticals

Verrica Pharmaceuticals Inc

$5.65
+0.01 (+0.18%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +69.7% upside
Low Target $7.88
Average Target $9.59
High Target $13.36
Current Price $5.65
Current
$5.65
Target
$9.59
$7.88 $9.59 avg $13.36
Scenario Analysis
Bear Case
$7.88
39.5%
Low target
Base Case
$9.59
+69.7%
Avg target
Bull Case
$13.36
+136.5%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$9.82
-42.5% from high
52-Week Low
$3.28
+72.3% from low
Target vs 52W High
$9.59
-2.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%